TCN2 and cancer: Furthermore, TCN2 downregulation in glioblastoma cell lines decreased cobalamin intracellular concentration in hypoxic conditions, stimulating the epithelial–mesenchymal transition (EMT) process, and promoting migratory and invasive properties, and cancer stem cell (CSC) differentiation [96].